Fig. 17From: Emerging biomaterials for tumor immunotherapyBPQD-RMNVs for tumor immunotherapy. A Schematic illustration of PTT and immunotherapy mediated by BPQD-RMNVs and aPD-1. B In vivo anti-tumor effect of BPQD-RMNV. (a) Average tumor volumes of the treated mice in the different groups. (b) Weights of tumors extracted from euthanized mice in the different groups. (Reproduced with permission from [119] Copyright © 2019, Elsevier)Back to article page